The challenge of palmoplantar pustulosis therapy: Are Interleukin-23 inhibitors an option?

Poortinga, S; Balakirski, G; Kromer, C; Mössner, R; Schön, M P; Bieber, T; Wilsmann-Theis, D

Poortinga, S; Balakirski, G; Kromer, C; Mössner, R; Schön, M P; Bieber, T; Wilsmann-Theis, D.

Afiliação

Poortinga S; Department of Dermatology and Allergology, University Hospital of Bonn, Bonn, Germany.
Balakirski G; Department of Dermatology and Allergology, University Hospital of Bonn, Bonn, Germany.
Kromer C; Department of Dermatology, Allergology and Dermatosurgery, HELIOS University Hospital Wuppertal, University of Witten/Herdecke, Wuppertal, Germany.
Mössner R; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Schön MP; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Bieber T; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Wilsmann-Theis D; Lower Saxony Institute of Occupational Dermatology, University Medical Center Göttingen, Göttingen, Germany.

J Eur Acad Dermatol Venereol ; 35(12): e907-e911, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34309915

Assuntos

Exantema; Psoríase; Dermatopatias Vesiculobolhosas; Doença Crônica; Humanos; Interleucina-23; Psoríase/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Dermatopatias Vesiculobolhosas / Exantema Limite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Assunto da revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google